[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:dpyd-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"DPYD Gene",3,2,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07158164","DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment",[12],"Phase 4","RECRUITING","2026-08-26T02:15:01.639696Z","2026-05-05T02:43:28.300380Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07290985","AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas",[20],"Phase 2","2026-08-26T02:17:07.954622Z","2026-07-24T01:27:14.911516Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT06489041","Evaluating Microarray Pharmacogenetic Testing in Cancer Patients",[],"ACTIVE_NOT_RECRUITING","2026-08-03T02:51:12.602181Z","2026-05-05T02:43:26.750733Z"]